Intel shares declined nearly 7% following reports that the company is in discussions with major investors for a discounted equity infusion. The move aims to raise capital amid ongoing challenges such as declining sales and stiff competition in the AI semiconductor market. Earlier, Intel announced a $2 billion investment from SoftBank, while rumors of government involvement surfaced. The company favors outside investors to avoid shareholder dilution and strengthen its financial position.